FDAnews
www.fdanews.com/articles/122998-elan-drops-doses-in-clinical-trial

Elan Drops Doses in Clinical Trial

December 15, 2009
Pharmaceutical firm Elan announced Tuesday it has dropped doses in a clinical trial of a new drug it has been testing for Alzheimer’s disease.
The Irish Times